Jennifer Morozink Boylan1, Carol D Ryff. 1. From the Department of Psychiatry (Boylan), University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Psychology and Institute on Aging (Ryff), University of Wisconsin-Madison, Madison, Wisconsin.
Abstract
OBJECTIVES: Psychological well-being predicts favorable cardiovascular outcomes, but less evidence addresses biological mediators underlying these effects. Therefore, associations among well-being and metabolic syndrome (MetSyn) were examined in a national sample. METHODS: Survey of Midlife in the US participants (MIDUS; n = 1205) provided survey assessments of hedonic (positive affect, life satisfaction) and eudaimonic well-being (e.g., personal growth and purpose in life) at two waves 9 to 10 years apart. MetSyn components were measured during an overnight clinic visit at Time 2 only. Outcomes included the number of MetSyn risk factors and a binary outcome reflective of MetSyn status. RESULTS: The unadjusted prevalence of MetSyn was 36.6%. Life satisfaction (B [standard error {SE}] = -0.12 [0.04], p = .005), positive affect (B [SE] = -0.10 [0.04], p = .009), and personal growth (B [SE] = -0.10 [0.04], p = .012) predicted fewer MetSyn components and lower risk of meeting diagnostic criteria in fully adjusted models. Results were unchanged by adjustments for depressive symptoms, and were not moderated by age, sex, race, or socioeconomic status. Life satisfaction (B [SE] = -0.11 [0.05], p = .023) and a eudaimonic well-being composite (B [SE] = -0.11 [0.05], p = .045) also predicted fewer components and lower risk of meeting diagnostic criteria in longitudinal models. CONCLUSIONS: Psychosocial resources, including positive affect, life satisfaction, and personal growth, predicted reduced risk for MetSyn both cross sectionally and longitudinally. Further work should examine consequences of these linkages for cardiovascular outcomes in intervention contexts.
OBJECTIVES: Psychological well-being predicts favorable cardiovascular outcomes, but less evidence addresses biological mediators underlying these effects. Therefore, associations among well-being and metabolic syndrome (MetSyn) were examined in a national sample. METHODS: Survey of Midlife in the US participants (MIDUS; n = 1205) provided survey assessments of hedonic (positive affect, life satisfaction) and eudaimonic well-being (e.g., personal growth and purpose in life) at two waves 9 to 10 years apart. MetSyn components were measured during an overnight clinic visit at Time 2 only. Outcomes included the number of MetSyn risk factors and a binary outcome reflective of MetSyn status. RESULTS: The unadjusted prevalence of MetSyn was 36.6%. Life satisfaction (B [standard error {SE}] = -0.12 [0.04], p = .005), positive affect (B [SE] = -0.10 [0.04], p = .009), and personal growth (B [SE] = -0.10 [0.04], p = .012) predicted fewer MetSyn components and lower risk of meeting diagnostic criteria in fully adjusted models. Results were unchanged by adjustments for depressive symptoms, and were not moderated by age, sex, race, or socioeconomic status. Life satisfaction (B [SE] = -0.11 [0.05], p = .023) and a eudaimonic well-being composite (B [SE] = -0.11 [0.05], p = .045) also predicted fewer components and lower risk of meeting diagnostic criteria in longitudinal models. CONCLUSIONS:Psychosocial resources, including positive affect, life satisfaction, and personal growth, predicted reduced risk for MetSyn both cross sectionally and longitudinally. Further work should examine consequences of these linkages for cardiovascular outcomes in intervention contexts.
Authors: Aaron S Heller; Carien M van Reekum; Stacey M Schaefer; Regina C Lapate; Barry T Radler; Carol D Ryff; Richard J Davidson Journal: Psychol Sci Date: 2013-09-20
Authors: Nadia van der Spek; Joël Vos; Cornelia F van Uden-Kraan; William Breitbart; Pim Cuijpers; Kitty Knipscheer-Kuipers; Vincent Willemsen; Rob A E M Tollenaar; Christi J van Asperen; Irma M Verdonck-de Leeuw Journal: BMC Psychiatry Date: 2014-01-28 Impact factor: 3.630
Authors: Stacey M Schaefer; Jennifer Morozink Boylan; Carien M van Reekum; Regina C Lapate; Catherine J Norris; Carol D Ryff; Richard J Davidson Journal: PLoS One Date: 2013-11-13 Impact factor: 3.240
Authors: Leila Shahabi; Kelly Karavolos; Susan A Everson-Rose; Tené T Lewis; Karen A Matthews; Kim Sutton-Tyrrell; Lynda H Powell Journal: Psychosom Med Date: 2016-05 Impact factor: 4.312
Authors: Loni Berkowitz; Marcela P Henríquez; Cristian Salazar; Eric Rojas; Guadalupe Echeverría; Gayle D Love; Attilio Rigotti; Christopher L Coe; Carol D Ryff Journal: Sci Rep Date: 2021-06-23 Impact factor: 4.379